InsidersTradesSigma
Track the UNI stock price and the full management transaction log of the company, a publicly traded company based in Australia. Shares are quoted on the AU market, under the oversight of ASX. Operating in the Health Care sector, UNI has logged 7 public disclosures. Market capitalisation: €622.2m. The latest transaction was disclosed on 31 August 2026 (Change in Substantial Holding). Among the most active insiders: Affiliates. The full history is accessible without an account.
Analysts rate UNI Strong Buy (bullish), based on 10 analysts. Average price target: A$10.30.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
7 of 7 declarations
UNI is a healthcare and pharmaceutical company listed on the XASX. It specializes in developing innovative solutions to enhance patient health.